Summary
Updated Aug 31, 2026
Charles Farkas is Director of CONMED Corp (CNMD). 2 SEC Form 4 filings on record going back to 2025, most recently on 3 June 2026. Most recent open-market trade: sold $48K of CNMD on 12 September 2025. Lifetime open-market sales: $107K.
Recent Transactions
3Every recent SEC Form 4 transaction Charles Farkas has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Charles Farkas go back to 2025: 2 primary Form 4 filings, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Charles Farkas files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Todd W. Garner - $151K of CNMD open-market activity in the last 12 months
- Richard Glaze - $11K of CNMD open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Charles Farkas?
Charles Farkas is a corporate insider, tracked as Director of CONMED Corp (CNMD). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Charles Farkas submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Charles Farkas been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($107K) across all tracked filings.
Where can I see all of Charles Farkas's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Charles Farkas and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial